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PURPOSE.We examined the relationship between retinal nerve fiber layer (RNFL) thickness and
cognitive function in a population of older British adults.
METHODS. Participants of the European Prospective Investigation of Cancer (EPIC) Norfolk
cohort study underwent ophthalmic and cognitive assessment. Measurements of RNFL
thickness were made using the Heidelberg Retina Tomograph (HRT). Cognitive testing
included a short form of the Mini-Mental State Examination (SF-MMSE), an animal naming task,
a letter cancellation task, the Hopkins Verbal Learning Test (HVLT), the National Adult
Reading Test (NART), and the Paired Associates Learning Test. Multivariable linear regression
models were used to assess associations of RNFL thickness with cognitive test scores, adjusted
for age, sex, education level, social class, visual acuity, axial length, and history of cataract
surgery.
RESULTS. Data were available from 5563 participants with a mean age of 67 years. A thicker
HRT-derived RNFL thickness was associated with better scores for the SF-MMSE (0.06; 95%
confidence interval [CI], [0.02, 0.10], P ¼ 0.005), HVLT (0.16, 95% CI [0.03, 0.29]; P ¼
0.014), and NART (0.24, 95% CI [0.46, 0.02], P ¼ 0.035). The associations of RNFL
thickness with SF-MMSE and HVLT remained significant following further adjustment for
NART.
CONCLUSIONS. We found a significant association between HRT-derived RNFL thickness and
scores from cognitive tests assessing global function, recognition, learning, episodic memory,
and premorbid intelligence. However, the associations were weak and not currently of
predictive value. Further research is required to confirm and clarify the nature of these
associations, and identify biological mechanisms.
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Cognition refers to mental activity including perception,planned action, and thought.1 Dementia is a decline of
cognitive function severe enough to interfere with social
function, not associated with alteration of consciousness.2
Alzheimer’s disease (AD) is the most common form of
dementia.2 It has been estimated that there were 24.3 million
people with AD worldwide in 2001, and that this will increase
to 42.3 million in 2020, and 81.1 million by 2040.3 While there
is no definitive therapy for AD, many experts believe that better
characterization of potential precursor syndromes is important,
and provides a target for possible preventative intervention in
the future.4,5 Definitive diagnosis of AD is possible only at
postmortem, the two main pathologic hallmarks being amyloid
plaques and neurofibrillary tangles.6 Practically, a clinical
diagnosis of AD usually is made, based on a careful history
from the patient or caregiver, and neuropsychologic testing.
Neuroimaging7 (including functional imaging8) and cerebrospi-
nal fluid analysis9 may help identify or confirm cases of AD, and
may form part of research diagnostic criteria.10 However,
optimal methods and thresholds for these biomarkers currently
are unknown6 and these tests are invasive or expensive, which
limits their practical use on a large scale in the community.
Identification of an affordable, noninvasive and acceptable
biomarker for cognitive function may aid the diagnosis of AD or
its precursor syndromes at a population level.
The optic nerve, unlike other cranial nerves, is surrounded
by myelin produced by oligodendrocytes (rather than Schwann
cells found in peripheral nerves), is encased by the meninges,
and has the same embryonic origins as the central nervous
system (CNS).11 Therefore, the optic nerve is considered part of
the CNS, and as such, is the only directly visible part of it.
Accurate measurements of the optic nerve head and surround-
ing retinal nerve fiber layer (RNFL) are now possible with
modern ophthalmic imaging devices.12 It is an attractive
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hypothesis that these measurements might correlate with CNS
structure or function, and that ocular imaging may provide an
easy and noninvasive ancillary examination for the diagnosis of
conditions, such as AD.13,14 Retinal nerve fiber layer thickness,
as measured by the Glaucoma Diagnosis device with Variable
Corneal Compensation (GDxVCC), was shown to be associat-
ed with cognitive function in healthy individuals from a
genetically isolated population in the Netherlands.15 We have
reported previously Heidelberg Retina Tomograph (HRT)
measured RNFL thickness to be associated with educational
attainment in the European Prospective Investigation of
Cancer (EPIC)–Norfolk Eye Study,16 which might suggest a
potential link with cognitive function.
The aim of this study was to examine the association of HRT
derived RNFL measures with cognitive function in the EPIC-
Norfolk cohort.
METHODS
EPIC-Norfolk is one of the UK arms of a pan-European
prospective cohort study; detailed methods have been
published elsewhere.17 In brief, 25,639 participants aged 40
to 79 years were recruited via general practices and examined
between 1993 and 1997. Since virtually all residents in the
United Kingdom are registered with a general practitioner
through the National Health Service (NHS), general practice
lists serve as population registers. Detailed ophthalmic
examination and testing of cognitive function formed part of
the third health examination of EPIC-Norfolk.18,19 In total,
8623 participants attended this examination between 2004 and
2011. EPIC-Norfolk was carried out following the principles of
the Declaration of Helsinki and the Research Governance
Framework for Health and Social Care. The study was approved
by the Norfolk Local Research Ethics Committee (05/Q0101/
191) and East Norfolk & Waveney NHS Research Governance
Committee (2005EC07L). All participants gave written, in-
formed consent.
Ocular Measurements
All participants were examined in the research clinic and
measurements were undertaken without pupil dilation by
trained nursing staff following standard operating procedures,
as detailed previously.19
Measurements of the RNFL were made using the HRT II
(Heidelberg Retina Tomogram II; Heidelberg Engineering,
Heidelberg, Germany). The HRT creates 3-dimensional images
of the optic nerve head using scanning laser ophthalmoscopy
and RNFL measurements are derived from the height of the
retina at the disc margin.20 Measurements using the HRT II
were taken after entering the participant’s keratometry and
refraction. If the HRT image quality was poor (topography
standard deviation >40 lm) a repeat scan was undertaken.
Contours around the disc margins were drawn manually and
subsequently checked by an ophthalmologist (and redrawn if
necessary). The HRT software subsequently was updated to
Glaucoma Module Premium Edition (software version 3.1) and
data exported following this. These derived data that are
equivalent to HRT3-derived parameters. Only scans with a
topography standard deviation 40 lm were included in
analyses. We considered the ‘‘mean RNFL thickness’’ parameter
which we have reported previously to be associated with
educational attainment.16
Axial length was measured using a Zeiss IOLMaster Optical
Biometer (Carl Zeiss Meditec Ltd, Welwyn Garden City, UK).
Five measurements were taken per eye and a mean value
calculated. Monocular visual acuity (VA) was measured using a
logMAR chart (Precision Vision, LaSalle, IL, USA) on a light box
under standard illumination. The test was performed with the
aid of the participant’s usual distance correction at 4 m (or 2 m,
then 1 m if unable to read any letters). The test was terminated
when the participant was able to read 3 letters on a line. The
presenting VA of the better eye was considered in analyses.
Cognitive Assessment
A battery of cognitive tests was done as part of the EPIC-
Norfolk third health examination.21 The tests included a short-
form of the Mini-Mental State Examination (SF-MMSE), an
animal naming task, a letter cancellation task, the Hopkins
Verbal Learning Test (HVLT), the National Adult Reading Test
(NART), and the Cambridge Neuropsychological Test Automat-
ed Battery Paired Associates Learning Test (PAL).
The MMSE is a widely used and studied screening measure
of cognitive impairment that contains 20 items with a potential
total score of 30.22 The SF-MMSE was administered in EPIC-
Norfolk, containing 11 items instead of 20, with a total possible
score of 15.23 The rationale for this is that some of the items on
the full MMSE may not be discriminating in a healthy
population with a low prevalence of cognitive impairment.24
The full MMSE was designed for clinical samples, not for
healthy population screening, and it is likely that some items
will be answered correctly by most participants.25 This being
the case, a shorter test without the easiest items would be
quicker to administer, and potentially nearly as discriminat-
ing.26 The SF-MMSE has been shown to discriminate similarly
to the full MMSE in another large population-based study.23 The
SF-MMSE assesses memory recall, attention and calculation,
object naming, registration, verbal registration, language, and
visual-spatial/constructional performance.
The animal naming task involved recording the number of
animals a participant can recall in 1 minute, which tests
semantic verbal fluency,27 an important part of the assessment
of patients with suspected dementia.28,29 The animal naming
task has performed well at discriminating individuals with AD
from those with normal cognitive function30,31 and predicted
incident AD in an epidemiologic sample from Canada.32
The letter cancellation task33 involved a visual search of a
grid of 780 random letters with the aim of crossing out as many
target letters (the letters P and W, of which there were a
possible 72) within 1 minute. The accuracy score (PW-
accuracy) is the number of target letters correctly identified
minus the number of target letters missed, and is a measure of
attention and concentration.
The HVLT34 required participants to memorize a 12-item
word list, composed of four words from 3 semantic categories
(precious stones, human shelter, and animals with four legs).
The words were displayed on a computer screen in very large
font with an interval of 1 second between each word
presentation. At the end of the presentation, the participant
was asked to recall as many of the words as possible. The list
was presented a further two times. The total score for the three
HVLT trials was considered, with a maximum possible score of
36.
A shortened version of the NART35 required participants to
correctly pronounce a set of 25 words of varying difficulty that
do not follow the usual grapheme-phoneme and stress rules of
pronunciation. These ‘‘irregular’’ words can be read correctly
only if the participant recognizes them in their written form.
The words were displayed in very large font on a computer
screen, with the participant in control of the pace of moving to
the next word. A score out of 50 was derived, as described
previously.35 A lower NART score indicates a better cognitive
performance.
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The PAL assessed episodic memory and new learning, and
has been shown to be very sensitive at detecting memory
deficit in the very early stages of dementia.36–38 Boxes were
displayed on a touch screen and opened in a random order to
reveal a distinct pattern in one or more boxes. After all the
boxes were opened, the pattern(s) were displayed in the
middle of the screen one at a time and the participant required
to touch the box which contained the pattern. There were 8
stages to the test and up to 10 repeat ‘‘reminder’’ presentations
of the pattern locations. The total number of errors made,
adjusted for the number of stages completed, was used in the
present analysis, with a lower PAL score indicating a better
cognitive performance.39
Social class and educational level were ascertained at the
first health examination. Social class was recorded according to
the Registrar-General’s occupation-based classification system
and was based on the participant’s last occupation if they were
retired. Educational level was recorded and classified into four
groups according to the highest qualification achieved.
Statistical Analysis
We considered the mean RNFL thickness of the right and left
eyes of each participant if good quality data from both eyes
were available. If only one eye had good quality data, that eye
was considered. Data for PAL were log-transformed to derive a
normal distribution. Mean and standard deviations for each of
the cognitive test scores were calculated for the whole cohort
and for quartiles of HRT mean RNFL thickness. A test of trend
across the quartiles for each cognitive test was done. Potential
confounders were decided a priori. Despite the large font on
test displays, visual acuity may influence performance on
cognitive tests as well as be related to RNFL thickness. Axial
length is known to be associated with RNFL thickness16,40 and
education level.41 A history of cataract surgery has been
associated with RNFL measurements,40 and it might be that
whether participants seek care for cataracts or not is related to
cognitive function. Disc area has been shown to be associated
with several HRT parameters, and variation in this parameter is
thought to be largely physiologic rather than pathologic.16 To
assess the effect of possible confounders on the association
between RNFL measures and cognitive function, we used
multivariable linear regression models with the cognitive score
as the dependent variable and the RNFL measure together with
covariables as the explanatory variables. We used three types
of multivariable model: adjustment for disc area, adjustment for
disc area and age, and adjustment for disc area, age, sex,
educational level, social class, visual acuity of the better eye,
axial length, and a history of cataract surgery (‘‘maximally
adjusted’’). Regression coefficients were calculated per stan-
dard deviation change of HRT RNFL thickness. Stata version
13.1 (StataCorp LP, College Station, TX, USA) was used for all
statistical analyses.
RESULTS
There were complete data for HRT RNFL thickness, cognitive
tests and covariables from 5563 participants with a mean age
of 67 years (range, 48–89); 56% were women. Compared to
participants who attended the EPIC-Norfolk Eye Study but
were excluded from analyses due to missing or poor quality
data (n ¼ 3060), included participants were significantly
younger (P < 0.001) and had higher educational attainment
(P < 0.001). Included and excluded participants did not differ
significantly by sex (P ¼ 0.06) or social class (P ¼ 0.17).
Mean scores for the cognitive tests in the whole cohort, and
also by HRT RNFL thickness quartiles are presented in Table 1.
There were statistically significant trends for a better cognitive
test score with thicker RNFL quartile for all cognitive tests.
Table 2 presents results from multivariable regression
models with progressive adjustment for possible confounders.
A thicker HRT RNFL measurement was associated with a better
score for all cognitive tests in analyses adjusted for disc area
only. Following adjustment for age and further adjustment for
TABLE 1. Mean (SD) Cognitive Scores for All Included Participants (n¼ 5563) and by Quartiles of HRT RNFL Thickness
SF-MMSE Animal Number PW-Accuracy HVLT NART* Log PAL*
All participants 13.42 (1.59) 23.39 (6.43) 12.75 (6.01) 25.53 (5.40) 17.21 (9.83) 3.18 (0.93)
HRT quartiles
Q1 (0.630 to 0.184) 13.30 (1.64) 22.93 (6.46) 12.17 (5.98) 24.81 (5.68) 17.48 (9.92) 3.26 (0.92)
Q2 (0.185 to 0.219) 13.31 (1.60) 23.04 (6.40) 12.54 (5.74) 25.08 (5.38) 18.02 (9.95) 3.23 (0.94)
Q3 (0.220 to 0.259) 13.45 (1.64) 23.44 (6.37) 13.04 (5.98) 25.64 (5.29) 17.37 (9.94) 3.18 (0.93)
Q4 (0.260 to 0.635) 13.60 (1.47) 23.99 (6.45) 13.16 (6.22) 26.38 (5.16) 16.22 (9.50) 3.07 (0.93)
Test for trend P < 0.001 P < 0.001 P < 0.001 P < 0.001 P < 0.001 P < 0.001
PW-accuracy, Ps and Ws accuracy.
* A lower score indicates a better cognitive performance for these measures.
TABLE 2. Regression Coefficients per SD Change in HRT RNFL Thickness, With Cognitive Scores as the Dependent Variables
Adjusted for Disc Area Adjusted for Disc Area and Age
Adjusted for Disc Area,
Age and Other Covariables*
b 95% CI P Value b 95% CI P Value b 95% CI P Value
MMSE 0.12 (0.07, 0.16) <0.001 0.06 (0.02, 0.11) 0.003 0.06 (0.02, 0.10) 0.005
Animal number 0.43 (0.26, 0.60) <0.001 0.17 (0.00, 0.34) 0.047 0.11 (0.06, 0.27) 0.20
PW accuracy 0.33 (0.17, 0.49) <0.001 0.05 (0.10, 0.21) 0.50 0.01 (0.16, 0.15) 0.93
HVLT 0.58 (0.44, 0.72) <0.001 0.27 (0.13, 0.40) <0.001 0.16 (0.03, 0.29) 0.014
NART† 0.49 (0.75, 0.23) <0.001 0.42 (0.69, 0.16) 0.002 0.24 (0.46, 0.02) 0.035
Log PAL† 0.07 (0.10, 0.05) <0.001 0.02 (0.04, 0.00) 0.11 0.01 (0.03, 0.02) 0.53
* Other covariables adjusted for were sex, education level, social class, visual acuity of the better eye, axial length, and history of cataract surgery.
† A lower score indicates a better cognitive performance for these measures.
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all covariables, significant associations remained between a
thicker HRT RNFL measure and better cognitive scores for SF-
MMSE, HVLT, and NART tests. We also examined the
associations of HRT RNFL thickness with SF-MMSE and HVLT
further adjusted for the NART score (which may represent
early life cognitive function rather than later cognitive change);
the associations remained statistically significant (SF-MMSE:
0.05, 95% confidence interval [CI; 0.01, 0.09], P¼0.015; HVLT:
0.14, 95% CI [0.01, 0.27], P ¼ 0.036).
The adjusted R2 for the maximally adjusted models were
0.092 for SF-MMSE, 0.214 for HVLT, and 0.149 for NART. The
adjusted R2 for the models only adjusted for disc area were
0.006 for SF-MMSE, 0.011 for HVLT, and 0.002 for NART.
DISCUSSION
In this population-based sample, we found thinner HRT-derived
mean RNFL thickness measures to be associated with poorer
performance for three tests (SF-MMSE, HVLT, and NART) which
assess several domains of cognitive function. The SF-MMSE is a
global measure of cognitive function,23 while the HVLT
assesses recognition, learning, and episodic memory.34 The
NART is an estimate of premorbid intelligence.35 These
associations remained following statistical adjustment for
possible confounders, including age.
The poorer cognitive performance we observed in partic-
ipants with thinner HRT RNFL measurements may have a few
different explanations. The association may be due to a thinner
RNFL measure reflecting poorer structural health of the CNS
and a greater degree of neurodegeneration, which in turn
might be related to a poorer cognitive function. If this is the
case, further refining of which attributes of RNFL structure
best relate to cognitive function would be of interest. As it
stands, the association we observed was statistically significant
but weak; HRT RNFL thickness alone explained no more than
1% of the variability of the cognitive scores and, therefore,
would be of limited predictive utility for cognitive function.
Our findings therefore, at present, do not support the concept
that HRT RNFL measures may act as a biomarker for cognitive
health.
Other possible explanations for our observed association
between HRT measured RNFL thickness and cognitive function
include residual confounding by either age or axial length.
Cognitive function42 and RNFL thickness16,40 are known to
decline with age. It is possible that linear adjustment for age
did not completely remove the confounding effect of age for
the association between HRT RNFL thickness and cognitive
function. However, results were similar following further
adjustment for the square of age (data not shown).
Longer axial length is associated with higher educational
attainment41 and this in turn may be associated with better
cognitive function). There is conflicting evidence regarding
how RNFL thickness varies with axial length. We have
previously reported thinner HRT-measured RNFL in longer
eyes using data from the present cohort.16 Therefore,
confounding by axial length is unlikely to explain an
association between HRT RNFL thickness and cognitive
function in our study population. Furthermore, additional
adjustment for the square of axial length did not significantly
alter our results (data not shown).
Five of the six cognitive tests examined in this study
required some visual input for successful completion (all
except the animal naming task). It is possible that thinner
RNFL is reflecting poorer vision and, therefore, worse
performance on cognitive tests requiring vision. However,
the prevalence of central visual impairment measured using
logMAR charts was very low in this cohort,19 and very large
font size was used for the words presented in the tests we
found significant associations with. Furthermore, we adjusted
analyses for VA. Therefore, it seems unlikely that the
association we observed between RNFL thickness and cogni-
tive function was explained entirely by variation in visual
function. It is unclear why we detected associations between
RNFL thickness and only three of the six cognitive measures. It
is possible that only cognitive decline in certain domains is
biologically associated with changes in the RNFL. A more likely
explanation is that our study was underpowered to consis-
tently detect small associations for all the cognitive tests.
It should be noted that while the HRT derived parameter is
termed ‘‘mean RNFL thickness,’’ it does not represent true
RNFL thickness in the same way as optical coherence
tomography (OCT). The parameter is derived from the height
of the retina above a reference plane at the disc margin, and,
therefore, can be considered a proxy measure rather than a
true anatomic measurement of the RNFL. Therefore, other
attributes of optic nerve head anatomy may be driving the
relationship with cognitive function than RNFL thickness per
se. For example, temporal tilt of the optic disc may result in
higher measures of HRT-derived RNFL thickness, and optic disc
tilt may be associated with cognitive function (though this is
not known).
Our study population included participants with glaucoma
and we purposely did not exclude these participants as they
may contribute important signal for the relationship between
optic nerve head measures and cognitive function. We
hypothesize that a primary neurodegenerative process may
contribute to cognitive decline and the etiology of primary
open-angle glaucoma. We conducted further analyses to
determine if the association between RNFL thickness and
cognitive function remained following exclusion of partici-
pants with glaucoma. There were 171 participants with a
history of either glaucoma medication use (n ¼ 143) and/or
glaucoma surgery (n ¼ 41). Following exclusion of these
participants, we repeated the analyses presented in Table 2 and
yielded similar results (Supplementary Table). The cognitive
scores were distributed normally in our population except for
PAL and SF-MMSE. The distribution for PAL was skewed and,
therefore, we analyzed log-transformed data as presented in
this study. The distribution for SF-MMSE displayed a ceiling
effect and was not amenable to transformation. As an
additional analysis, we carried out a logistic regression analysis
for SF-MMSE as a binary outcome variable (defined by the
median value: participants scoring < 14 versus participants
scoring ‡ 14); the maximally adjusted association remained
highly significant (odds ratio per SD change in RNFL thickness,
1.10; 95% CI [1.04, 1.17]; P ¼ 0.002).
There are two other published reports examining the
relationship between RNFL measures and cognitive function in
healthy populations.15,43 Our findings, in part, are in agree-
ment with results from a similar study of 1485 individuals from
the Erasmus Rucphen Family (ERF), which also reported
thinner RNFL to be associated with poorer scores for several
different cognitive tests.15 In agreement with our study, the
effect estimates detected in the ERF study were small
suggesting poor predictive value. In a small OCT study of 96
participants from the Lothian Birth Cohort 1936, thicker
inferior RNFL was associated with better general processing
speed (a principal component of several cognitive test scores)
after adjusting for age and sex.43 Following further adjustment
for IQ score at age 11, several more significant associations
between OCT RNFL parameters and cognitive components
were found, but in a direction consistent with better cognitive
functioning in participants with thinner RNFL.43 To our
knowledge, our study is the largest study to date examining
the association between RNFL measures and cognitive function
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in healthy adults, and in contrast to the ERF study, our cohort
sampled the general population rather than an in-bred
population.
Further evidence for an association between RNFL mea-
sures and cognitive function comes from studies demonstrat-
ing thinner RNFL in patients with AD or mild cognitive
impairment compared to controls, as measured by HRT44 or
OCT.45–48 Furthermore, there also is histopathologic evidence
of optic nerve and retinal changes in AD. Studies involving
postmortem examination of eyes from patients with AD have
found significant differences in comparison with eyes from age-
matched controls.49–51 There also are several studies associat-
ing AD with glaucoma.52–55 A link between these two diseases
would support the concept of an underlying generalized
susceptibility to neurodegeneration causing the association
between RNFL measures and cognition. The risk of incident
dementia in 812 participants of the Three-City-Bordeaux-
Alienor study was 4-fold higher in those diagnosed with
glaucoma at baseline (odds ratio, 3.9; 95% CI, 1.5–10.4).55
Wostyn et al.56 have hypothesized that the association between
AD and glaucoma is causal, mediated by a lower cerebrospinal
fluid pressure.
Strengths of the present study include the large sample size
and the population-based design. There are several limitations
of our study. The number of participants included in the
current study represent a relatively small subset of the original
baseline cohort, largely because the cognitive and ophthalmic
assessment occurred at the third health examination which
began over 10 years after baseline examination; this may
induce a survivor bias. Participants excluded from analyses
were older and less educated than included participants; the
effect of this would be to truncate distributions and reduce
statistical power to detect associations unless the associations
are in the opposite direction for those excluded, which is
unlikely. Our data are cross-sectional, and, therefore, it is not
possible to assess whether RNFL measures can predict future
cognitive decline from this study. Arguably, prediction of future
cognitive decline would be most of interest, and examining
this may become a future study as the current cohort continues
follow-up. Another limitation is that the HRT is becoming used
less commonly in routine clinical assessment of ophthalmic
patients with the increasing popularity of OCT.57
In summary, we found significant associations between
HRT-derived RNFL thickness and several domains of cognitive
function. While the strength of association limits any predictive
value of HRT measures for cognitive function at present, these
findings suggest further study of the relationship between
retinal neuroanatomy and cognitive function is worthwhile.
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